In April 2026, the company obtained NMPA approval for a disposAble medical temperature sensor (Registration No. 吉械注准20262070103). In January-March 2026, the company completed registration renewals for 14 products. In March 2025, the company was selected for the National SME Digital Transformation City Pilot Program (first batch of subsidized enterprises) and the Jilin Province Innovation-Driven Development Project (Flushing and Suction Perfusion Catheter). The company holds 48 medical device product registrations.
Company Profile (Updated April 2026)
Jilin Wohong Medical Device Manufacturing Co., Ltd. (吉林省沃鸿医疗器械制造有限公司) is a national high-tech enterprise and a Jilin Province and Changchun City "Specialized, Refined, Distinctive, and Innovative" SME, engaged in the scientific research, development, production, sales, and technical services of medical polymer materials, non-invasive ventilators, and hygiene materials. Founded on April 17, 2009 (per business registration records); the company website states January 2013. Headquartered in Changchun, Jilin Province, China, the company is a private limited liability company invested and controlled by natural persons.
The company's headquarters and sales center are located in Xinxingyu Shangyu, Nanguan District, Changchun, with an office area of approximately 600 sqm. Its production base is situated in Kalun Industrial Zone, Jiutai Economic Development Zone, Changchun, covering approximately 50,000 sqm of land with independent property rights, and a building area of approximately 30,000 sqm. The company operates four Class 100,000 clean workshops totaling approximately 7,000 sqm and warehouse space of approximately 4,000 sqm.
Core Mission: "Scientific and dedicated manufacturing is our consistent pursuit; innovation, safety, and effectiveness are the directions of our continuous efforts; unity, diligence, and integrity are the spiritual forces driving our progress." The company adheres to the business philosophy of focusing on the medical device field and maintaining the advancement of product technology.
Corporate Governance
Legal Representative / Executive Director / General Manager:
- Yu Bo (于波): Per QichACHa and Liepin business registration data; holds 70% stake (RMB 35 million)
- Li Wei (李伟): Per Qixinbao, 36Kr, and Baidu Baike data; listed as legal representative and general manager
Note: Public sources show discrepancies regarding the legal representative. Yu Bo and Li Wei may be the same person (name change) or there may have been a leadership transition. Further verification is required.
Shareholders:
- Yu Bo (于波): 70% stake (RMB 35 million); capital contribution deadline December 31, 2025
- Xu Naifu (徐乃夫): 30% stake (RMB 15 million)
Quality Policy: "Abide by laws and regulations, quality first, customer supreme, continuous improvement."
Certifications and Honors
- National High-Tech Enterprise
- Jilin Province "Specialized, Refined, Distinctive, and Innovative" SME
- Changchun City "Specialized, Refined, Distinctive, and Innovative" SME
- ISO 13485:2012 Medical Device Quality Management System Certification (passed in 2017)
- ISO 9001 Quality Management System Certification (passed in 2014)
- EU CE Certification (passed in 2017)
- Production License: 吉食药监械生产许20170059号
- March 2025: Selected for the Jilin Province Innovation-Driven Development Project (Flushing and Suction Perfusion Catheter project)
- March 2025: Selected for the National SME Digital Transformation City Pilot Program — First Batch of Subsidized Enterprises
R&D and Intellectual Property
R&D Centers: Two R&D centers located in Beijing, with 10 R&D personnel
Patents:
- 33 patents in total, including 6 invention patents (per company official website)
- 36 national patents, including 7 invention patents (per Zhaopin recruitment data)
Product Registrations: 48 medical device product registrations
Jilin-Exclusive Products:
- 18 products are exclusively produced in Jilin Province (per company official website)
- 26 products fill the gap of similar products in Jilin Province (per Zhaopin recruitment data)
Products Under Registration: 6
Products in R&D: 15
R&D Investment: Annual R&D investment is no less than 8% of revenue
Key R&D Project: "High-Performance Non-Invasive Ventilator" — listed in the Made in china 2025 Jilin Implementation Outline, supported by the Jilin Provincial Department of Industry and Information Technology, Jilin Provincial Department of Science and Technology, and Changchun Municipal Bureau of Science and Technology
Product Portfolio
Medical Polymer Materials and Consumables (Class II and III)
- Disposable Sterile Temperature-Sensing Urinary Catheter / Kit
- Disposable Sterile Humidified Nasal Oxygen Cannula
- Disposable Sterile Nasogastric Tube
- Disposable Sterile Endoscopic Stone Retrieval Basket
- Disposable Sterile Biliary Drainage Tube
- Disposable Sterile Ureteral Stent Set
- Disposable Sterile Urinary Catheter / Kit (Silicone)
- Disposable Medical Temperature Sensor (newly approved April 2026, Registration No. 吉械注准20262070103)
- Disposable Underpad
- Patient Transfer Pad
- Disposable Sterile Protective Cover
- Disposable Oral Kit
Non-Invasive Ventilators (Class II Active Devices)
- Single-Level Non-Invasive Ventilator (CPAP)
- Dual-Level Non-Invasive Ventilator (BiPAP)
- High-Performance Non-Invasive Ventilator (key project under Made in China 2025 Jilin Implementation Outline)
Surgical and Nursing Equipment (Class II)
- Flushing and Suction Perfusion Catheter (selected for Jilin Province Innovation-Driven Development Project in 2025)
- Operating room, emergency room, and treatment room equipment and apparatus
- Ward nursing equipment and apparatus
Medical Optical Instruments (Class II)
- Medical optical instruments, instruments, and endoscope equipment
2025-2026 Latest Developments
New Product Approvals (2026)
- April 7, 2026: Disposable Medical Temperature Sensor approved by Jilin Provincial Medical Products Administration (Registration No. 吉械注准20262070103)
Registration Renewals (January-March 2026)
January 2026 (Announcement No. 1, January 10, 2026):
- Disposable sterile ureteral guidewire sheath (吉械注准20212020004)
- Disposable tissue puncture suspension fixator (吉械注准20212020035)
- Disposable sterile drainage tube set (吉械注准20212140032)
- Disposable sterile ureteral stent set (吉械注准20212140095)
- Disposable sterile nasogastric tube (吉械注准20212140094)
March 2026 (Announcement No. 2, March 4, 2026):
- Oral implant disposable irrigation tube (吉械注准20212170417)
- Disposable surgical pack (吉械注准20212140419)
- Disposable dressing change pack (吉械注准20212140394)
- Disposable sterile humidified nasal oxygen cannula (吉械注准20212080110)
Registration Renewals (April 2026)
Multiple products completed registration renewal in April 2026:
- Disposable Sterile Biliary Drainage Tube (吉械注准20212140538)
- Disposable Underpad (吉械注准20212140420)
- Patient Transfer Pad (吉械注准20212150422)
- Disposable Sterile Protective Cover (吉械注准20212140393)
- Disposable Oral Kit (吉械注准20212170395)
- Disposable Sterile Temperature-Sensing Urinary Catheter (吉械注准20212140309)
- Disposable Sterile Urinary Catheter (吉械注准20212140310)
Innovation and Digital Transformation (March 2025)
- Selected for the Jilin Province Innovation-Driven Development Project for the "Flushing and Suction Perfusion Catheter" project
- Selected for the National SME Digital Transformation City Pilot Program (first batch of subsidized enterprises), supporting digital transformation of production and management systems
Talent Recruitment (2026)
The company is actively recruiting in 2026 for positions including:
- Medical device mechanical engineers
- R&D engineers
- International registration engineers
Company Basic Information
Corporate Overview
Company Full Name: Jilin Wohong Medical Device Manufacturing Co., Ltd. (吉林省沃鸿医疗器械制造有限公司)
Founded: April 17, 2009 (business registration); company website states January 2013
Legal Representative / Executive Director / General Manager:
- Yu Bo (于波) (per Qichacha and Liepin; 70% shareholder)
- Li Wei (李伟) (per Qixinbao, 36Kr, and Baidu Baike)
Note: Public sources show discrepancies regarding the legal representative. The relationship between these names requires further verification.
Shareholders: Yu Bo (70%) and Xu Naifu (30%)
Registered Capital: RMB 50 million
Actual Investment: RMB 200 million (per official website) / RMB 50 million (per Liepin) — statistical discrepancy exists between sources
Unified Social Credit Code: 912201816833761618
Organization Code: 683376161
Registration No.: 220181020006275
Production License: 吉食药监械生产许20170059号
Company Type: Limited Liability Company (Natural Person Investment or Holding)
Industry: Medical Devices / Medical Polymer Materials / Medical Equipment Manufacturing
Employees: Approximately 200 (including nearly 20 with senior technical titles; 9 R&D engineers and technicians)
Headquarters Address: Xinxingyu Shangyu, Nanguan District, Changchun, Jilin, China
Production Base Address: Kalun Industrial Zone, Jiutai Economic Development Zone, Changchun, Jilin, China
Official Website: www.wohongyiliao.cn
Telephone: +86-0431-85306855
Business Scope
Production and sales of Class I, II, and III medical devices; Class II and III 6866 medical polymer materials and products; Class II 6864 hygiene materials and dressings; Class II 6854 operating room, emergency room, and treatment room equipment and apparatus; Class II 6856 ward nursing equipment and apparatus; Class II 6822 medical optical instruments, instruments, and endoscope equipment; disinfection and sterilization products; daily protective masks; housing and site leasing; labor and warehousing services (excluding hazardous chemicals); wholesale and import/export of other medical supplies and equipment.
Production Capacity and Quality System
Production Base: Kalun Industrial Zone, Jiutai Economic Development Zone, Changchun
- Land Area: Approximately 50,000 sqm (independent property rights)
- Building Area: Approximately 30,000 sqm
- Office Area: Approximately 10,000 sqm
- Clean Workshops: Four Class 100,000 clean workshops, approximately 7,000 sqm
- Warehouse: Approximately 4,000 sqm
Quality Management System: Established in 2012, passed ISO 9001 and ISO 13485 in 2014, and introduced internal control management in January 2016
Production Standards: All clean workshops meet Class 10,000 (ISO 7) standards
2026 Outlook and Strategic Priorities
Strategic Focus Areas
- Product Innovation: Continue advancing 15 products in R&D and 6 products under registration, maintaining technological synchronization with domestic and international markets
- Digital Transformation: Leverage national SME digital transformation pilot program support to upgrade production automation and management informatization
- High-Performance Ventilators: Advance the "High-Performance Non-Invasive Ventilator" project under the Made in China 2025 Jilin Implementation Outline
- Exclusive Product Leadership: Maintain and expand Jilin-exclusive product lines to strengthen regional competitive advantages
- Quality Excellence: Uphold the quality policy of "abide by laws and regulations, quality first, customer supreme, continuous improvement"
- Market Expansion: Expand domestic sales networks and explore export opportunities leveraging CE certification
- Talent Development: Recruit mechanical engineers, R&D engineers, and international registration specialists to support growth
Competitive Advantages
- Full Industry Chain Integration: Independent R&D, production, and sales with complete quality management systems
- Large-Scale Production Base: 50,000 sqm self-owned land with 30,000 sqm building area and Class 100,000 clean workshops
- Product Exclusivity: Multiple products exclusively produced in Jilin Province, creating strong regional market barriers
- Dual R&D Centers: Beijing-based R&D centers ensuring access to top-tier talent and technological resources
- Government Recognition: National high-tech enterprise, provincial and municipal "Specialized, Refined, Distinctive, and Innovative" SME, and recipient of multiple government innovation grants
- International Certifications: ISO 13485, ISO 9001, and CE certifications enabling export competitiveness
Risk Factors
- Leadership Verification: Discrepancies in public records regarding legal representative identity require resolution
- Policy Pressure: Centralized procurement and pricing reforms in the medical device sector may impact profit margins
- Competition: Intense competition from domestic and international medical device manufacturers in the low-value consumables segment
- R&D Execution: Need to successfully commercialize 15 products in R&D and maintain innovation pipeline
- Regulatory Compliance: Continuous need to maintain quality system certifications and product registration renewals
Contact Information
Headquarters
Address: Xinxingyu Shangyu, Nanguan District, Changchun, Jilin, China
Tel: +86-0431-85306855
Website: www.wohongyiliao.cn
Production Base
Address: Kalun Industrial Zone, Jiutai Economic Development Zone, Changchun, Jilin, China
Keywords: Jilin Wohong Medical Device Manufacturing,吉林省沃鸿医疗器械制造有限公司,沃鸿医疗,Wohong Medical,National High-Tech Enterprise,Specialized Refined Distinctive Innovative SME,Medical Polymer Materials,Non-Invasive Ventilator,Urinary Catheter,Biliary Drainage Tube,Nasal Oxygen Cannula,Endoscopic Stone Retrieval Basket,Ureteral Stent,Temperature Sensor,Flushing and Suction Perfusion Catheter,ISO 13485,CE Certification,Changchun,Jiutai Economic Development Zone,Made in China 2025
You May Also Like
-
Reflow Medical, Inc. - Pioneer of Retrievable Scaffold Therapy for Complex Cardiovascular Disease
Reflow Medical, Inc. is a global medical device company pion... -
inno-train Diagnostik GmbH - Global Leader in HLA & Molecular Blood Group Diagnostics
inno-train Diagnostik GmbH is a global leader in HLA (Human... -
Sansure Biotech Inc. (圣湘生物科技股份有限公司) - Global Leader in Molecular Diagnostics & Gene Technology
Sansure Biotech Inc. (圣湘生物科技股份有限公司) is a global leader in mo... -
Guangzhou Donghong Instrument Development Co., Ltd. (广州东弘仪器开发有限公司) - Innovative Laboratory and Bioph
Guangzhou Donghong Instrument Development Co., Ltd. (广州东弘仪器开... -
Prima (Nanjing) Biotechnology Co., Ltd. (普睿玛(南京)生物科技有限公司) - Innovative Pathology Diagnostics High-Te
Prima (Nanjing) Biotechnology Co., Ltd. (普睿玛(南京)生物科技有限公司) is... -
Jilin Wohong Medical Device Manufacturing Co., Ltd. (吉林省沃鸿医疗器械制造有限公司) - National High-Tech Medical D
Jilin Wohong Medical Device Manufacturing Co., Ltd. (吉林省沃鸿医疗... -
AIOBIO Co., Ltd. - AI-Powered Dental Diagnostics Pioneer
AIOBIO Co., Ltd. is a South Korean healthcare technology com... -
Tandem Diabetes Care, Inc. - Leading Insulin Delivery and Diabetes Technology Innovator
Tandem Diabetes Care, Inc. is a global insulin delivery and... -
Beijing Coyote Bioscience Co., Ltd. (北京卡尤迪生物科技股份有限公司) - Pioneer in POCT Molecular Diagnostics
Beijing Coyote Bioscience Co., Ltd. (北京卡尤迪生物科技股份有限公司) is a n... -
Danaher Corporation (丹纳赫公司) - Global Life Sciences and Diagnostics Innovator
Danaher Corporation (丹纳赫公司) is a leading global life science... -
Zybio Inc. (中元汇吉生物技术股份有限公司) - Leading Chinese Full-Line IVD Solutions Provider
Zybio Inc. (中元汇吉生物技术股份有限公司) is one of China's leading in vit... -
Guangzhou Weimi Bio-Tech Co., Ltd. (广州市微米生物科技有限公司) - Innovative Chinese IVD and POCT Solutions Provi
Guangzhou Weimi Bio-Tech Co., Ltd. (广州市微米生物科技有限公司) is a nati...
网友评论
- Popular Tags
-
- USA
- California
- China
- Germany
- Korea
- Abbott
- Massachusetts
- Shanghai
- Florida
- Israel
- Guangdong
- Japan
- Zhejiang
- Illinois
- QIAGEN
- ARKRAY
- France
- Ireland
- Beijing
- British Columbia
- Canada
- Seoul
- Michigan
- Jiangsu
- Arizona
- Netherlands
- 3M
- Minnesota
- North Rhine-Westphalia
- Agilent
- Ningbo
- Sansure
- Washington
- New York
- 爱科来
- Finland
- Medtronic
- Singapore
- Munich
- Suzhou
- Hessen
- Tokyo
- Mentor
- Missouri
- Johnson
- SynCardia
- Fujirebio
- Gyeonggi-do
- Robocath
- Autobio
- Follow Us
-

Scan the QR code to follow our WeChat Official Account

